Follow
Immunotherapy
Immunotherapy: is a type of cancer treatment the helps the immune system to fight cancer. The immune system helps your body fight infections and other diseases. It uses substances made by the body or in a laboratory in order to improve or restore the body's immune system function.
What's Popular in Immunotherapy
-
NOV 20, 2025Immunology
Immunotherapy has revolutionized the way physicians treat patients. Previously, chemotherapy was the standard-of-care wi ...Written By: Brian G. MorrealeNOV 20, 2025Immunology
Researchers recently developed a bone marrow model to study how the body generates cells. Interestingly, this model is t ...Written By: Brian G. MorrealeNOV 04, 2025Drug Discovery & Development
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...Written By: Annie LennonOCT 30, 2025Immunology
Scientists have developed a way to engineer immune cells that specifically target tumors. The application of engineering ...Written By: Brian G. MorrealeOCT 27, 2025eBooksAddressing TCE Discovery Challenges with Expert Insights T-cell engagers (TCEs) are revolutionizing cancer immunotherapy ...Sponsored By: WuXi Biologics CRO Services
NOV 20, 2025
Immunology
Immunotherapy has revolutionized the way physicians treat patients. Previously, chemotherapy was the standard-of-care wi
...
Written By:
Brian G. Morreale
NOV 20, 2025
Immunology
Researchers recently developed a bone marrow model to study how the body generates cells. Interestingly, this model is t
...
Written By:
Brian G. Morreale
NOV 04, 2025
Drug Discovery & Development
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing
...
Written By:
Annie Lennon
OCT 30, 2025
Immunology
Scientists have developed a way to engineer immune cells that specifically target tumors. The application of engineering
...
Written By:
Brian G. Morreale
OCT 27, 2025
eBooks
Addressing TCE Discovery Challenges with Expert Insights T-cell engagers (TCEs) are revolutionizing cancer immunotherapy
...
Sponsored By:
WuXi Biologics CRO Services
OCT 25, 2025
Cancer
A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals o
...
Written By:
Katie Kokolus
OCT 23, 2025
Immunology
Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a
...
Written By:
Brian G. Morreale
OCT 23, 2025
Immunology
The immune system works to identify and target invading pathogens. Specifically, our bodies work to get rid of any harmf
...
Written By:
Brian G. Morreale
OCT 16, 2025
Immunology
Cancer is classified as the uncontrollable growth of mutated cells. There are different types of cancers that correlate
...
Written By:
Brian G. Morreale
-
DEC 18, 2025 | 8:00 AM
Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success...NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...OCT 22, 2025 | 12:00 PM
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
OCT 17, 2025 | 8:00 AM
Hepatobiliary cancers, including hepatocellular carcinoma (HCC) and gallbladder cancer (GBC), are strongly linked to chronic inflammation. Recent research using the Olink PEA Technology sugg...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
DEC 18, 2025 | 8:00 AM
Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success...
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
OCT 22, 2025 | 12:00 PM
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
OCT 17, 2025 | 8:00 AM
Hepatobiliary cancers, including hepatocellular carcinoma (HCC) and gallbladder cancer (GBC), are strongly linked to chronic inflammation. Recent research using the Olink PEA Technology sugg...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
JUN 10, 2025 | 8:00 AM
Bispecific antibodies (bsAbs) represent a versatile and increasingly important class of targeted therapeutics, designed to bind two distinct sites — either two different epitopes on th...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
APR 23, 2025 | 1:00 AM
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...OCT 08, 2025 | 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...OCT 01, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...SEP 10, 2025 | 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
OCT 08, 2025
| 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
SEP 10, 2025
| 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
SEP 25, 2024
| 11:30 PM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...
JUL 24, 2024
| 6:00 AM PDT
GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering . This event will feature leading experts from academia, pharma, and biotech, showcasing the tra...